Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Oct;80(4):998–1008. doi: 10.1172/JCI113194

Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency.

J E Davis 1, R R Rich 1, M Van 1, H V Le 1, M S Pollack 1, R G Cook 1
PMCID: PMC442338  PMID: 2443540

Abstract

We have segregated DR1+ individuals into two categories according to whether or not their class II+ cells stimulated T lymphocyte clones specific for or restricted to DR1. In a majority of cases (87%), failure to stimulate was a property of cells having the B14;DR1 haplotype and/or nonclassical 21-hydroxylase deficiency. Absence of clonal proliferation could not be explained by release of an intercellular suppressor factor or by stimulator cell absorption of interleukin 2. Homozygous cells inheriting both stimulatory (DR1n) and nonstimulatory (DR1x) haplotypes did not successfully mediate clonal expansion, implying that a trans acting factor operates intracellularly to modify both DR1 alleles or their products. Other DR alleles did not appear to be affected as evidence by normal proliferative responses of T lymphocyte clones restricted to DR2 or DR7 and stimulated by DR1x,2 and DR1x,7 cells, respectively. By two-dimensional gel analysis, we have further identified a 50-kD surface glycoprotein contained in anti-DR immunoprecipitates of DR1x, but not DR1n or non-DR1 cellular lysates. This 50-kD structure had antigenic and peptide identity to DR alpha and beta chains but was resistant to dissociation under conditions that normally separate DR alpha and beta (8 M urea plus 5% 2-mercaptoethanol); boiling in sodium dodecyl sulfate was required to segregate the component polypeptides of the 50-kD heterodimer. We postulate that a product of a novel combinatorial association between constitutive chains of DR may interfere with or compete for normal T cell receptor recognition of DR1 as both an alloantigen and a restricting element. We further propose that gene abnormalities within the class III region of a haplotype associated with nonclassical 21-hydroxylase deficiency may extend into the DR subregion of the major histocompatibility complex with consequent aberrations in DR1 presentation.

Full text

PDF
998

Images in this article

1003Image
on p.1003
1003Image
on p.1003
1003Image
on p.1003
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1004Image
on p.1004
1005Image
on p.1005
1005Image
on p.1005
1005Image
on p.1005
1005Image
on p.1005
1006Image
on p.1006
1006Image
on p.1006

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brodsky F. M., Parham P., Bodmer W. F. Monoclonal antibodies to HLA--DRw determinants. Tissue Antigens. 1980 Jul;16(1):30–48. doi: 10.1111/j.1399-0039.1980.tb00285.x. [DOI] [PubMed] [Google Scholar]
  2. Brown M. F., Van M., Abramson S. L., Fox E. J., Rich R. R. Cellular requirements for induction of human primary proliferative responses to trinitrophenyl-modified cells. J Immunol. 1984 Jan;132(1):19–24. [PubMed] [Google Scholar]
  3. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  4. Carroll M. C., Campbell R. D., Porter R. R. Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A. 1985 Jan;82(2):521–525. doi: 10.1073/pnas.82.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977 Feb;104(2):255–262. doi: 10.1016/0014-4827(77)90089-1. [DOI] [PubMed] [Google Scholar]
  6. Chen Y. X., Evans R. L., Pollack M. S., Lanier L. L., Phillips J. H., Rousso C., Warner N. L., Brodsky F. M. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10. Hum Immunol. 1984 Aug;10(4):221–235. doi: 10.1016/0198-8859(84)90088-0. [DOI] [PubMed] [Google Scholar]
  7. Cleveland D. W., Fischer S. G., Kirschner M. W., Laemmli U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977 Feb 10;252(3):1102–1106. [PubMed] [Google Scholar]
  8. Hanke J. H., Brown M. F., Pollack M. S., Rich R. R. Class II determinants recognized by TNP-specific cloned human T cell lines. Hum Immunol. 1985 Sep;14(1):59–76. doi: 10.1016/0198-8859(85)90065-5. [DOI] [PubMed] [Google Scholar]
  9. Hanke J. H., Cook R. G., Leone J. W., Van M., Rich R. R. Molecular characterization of a subtype of DQw1 recognized by hapten-specific T cells. Immunogenetics. 1986;24(4):209–216. doi: 10.1007/BF00364524. [DOI] [PubMed] [Google Scholar]
  10. Hercend T., Reinherz E. L., Meuer S., Schlossman S. F., Ritz J. Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature. 1983 Jan 13;301(5896):158–160. doi: 10.1038/301158a0. [DOI] [PubMed] [Google Scholar]
  11. Kaufman J. F., Auffray C., Korman A. J., Shackelford D. A., Strominger J. The class II molecules of the human and murine major histocompatibility complex. Cell. 1984 Jan;36(1):1–13. doi: 10.1016/0092-8674(84)90068-0. [DOI] [PubMed] [Google Scholar]
  12. Kornbluth J., Dupont B. Cloning and functional characterization of primary alloreactive human T lymphocytes. J Exp Med. 1980 Aug 1;152(2 Pt 2):164s–181s. [PubMed] [Google Scholar]
  13. Lampson L. A., Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol. 1980 Jul;125(1):293–299. [PubMed] [Google Scholar]
  14. Maurer D. H., Collins W. E., Hanke J. H., Van M., Rich R. R., Pollack M. S. Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferation. Hum Immunol. 1985 Nov;14(3):245–258. doi: 10.1016/0198-8859(85)90232-0. [DOI] [PubMed] [Google Scholar]
  15. Pollack M. S., Keenan B., Christiansen F. T., Cobain T. J., Dawkins R. L., Clayton G. The immunological detection of a 21-OH deficiency mutation HLA supratype. Am J Hum Genet. 1986 May;38(5):688–698. [PMC free article] [PubMed] [Google Scholar]
  16. Raum D., Awdeh Z., Anderson J., Strong L., Granados J., Teran L., Giblett E., Yunis E. J., Alper C. A. Human C4 haplotypes with duplicated C4A or C4B. Am J Hum Genet. 1984 Jan;36(1):72–79. [PMC free article] [PubMed] [Google Scholar]
  17. Seldin M. F., Rich R. R. Human immune responses to hapten-conjugated cells. I. Primary and secondary proliferative responses in vitro. J Exp Med. 1978 Jun 1;147(6):1671–1683. doi: 10.1084/jem.147.6.1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Spits H., Borst J., Giphart M., Coligan J., Terhorst C., De Vries J. E. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur J Immunol. 1984 Apr;14(4):299–304. doi: 10.1002/eji.1830140404. [DOI] [PubMed] [Google Scholar]
  19. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  20. Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981 Apr;126(4):1393–1397. [PubMed] [Google Scholar]
  21. Watson A. J., DeMars R., Trowbridge I. S., Bach F. H. Detection of a novel human class II HLA antigen. 1983 Jul 28-Aug 3Nature. 304(5924):358–361. doi: 10.1038/304358a0. [DOI] [PubMed] [Google Scholar]
  22. Watson J. Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med. 1979 Dec 1;150(6):1510–1519. doi: 10.1084/jem.150.6.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Weiner M. S., Bianco C., Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood. 1973 Dec;42(6):939–946. [PubMed] [Google Scholar]
  24. White P. C., Grossberger D., Onufer B. J., Chaplin D. D., New M. I., Dupont B., Strominger J. L. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1089–1093. doi: 10.1073/pnas.82.4.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. White P. C., New M. I., Dupont B. Adrenal 21-hydroxylase cytochrome P-450 genes within the MHC class III region. Immunol Rev. 1985 Oct;87:123–150. doi: 10.1111/j.1600-065x.1985.tb01148.x. [DOI] [PubMed] [Google Scholar]
  26. White P. C., Werkmeister J., New M. I., Dupont B. Steroid 21-hydroxylase deficiency and the major histocompatibility complex. Hum Immunol. 1986 Apr;15(4):404–415. doi: 10.1016/0198-8859(86)90018-2. [DOI] [PubMed] [Google Scholar]
  27. Wu Y., Ernberg I., Masucci M. G., Johnson D., Klein E., Klein G. Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytes. J Immunol Methods. 1982;51(1):35–44. doi: 10.1016/0022-1759(82)90379-9. [DOI] [PubMed] [Google Scholar]
  28. Zeevi A., Scheffel C., Annen K., Bass G., Marrari M., Duquesnoy R. J. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants. Immunogenetics. 1982;16(3):209–218. doi: 10.1007/BF00343310. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES